Results 31 to 40 of about 22,174 (220)

Outbreak of varicella in a highly vaccinated preschool population

International Journal of Infectious Diseases, 2015
Background: Varicella vaccine is available for private purchase in Beijing, with single dose recommended for children aged ≥12 months before 2013. Despite the success achieved in reducing varicella incidence, varicella outbreaks continued to occur ...
Jiye Fu, Juguang Wang, Chu Jiang, Rujing Shi, Tianwei Ma   +4 more
doaj   +1 more source

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. [PDF]

, 2010
BACKGROUND: The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes of most industrialised countries and recently in two African GAVI eligible countries (Rwanda and The Gambia). However the long term effects of
George, Robert, Robert George, Y.H. Choi, Miller, Elizabeth, Edmunds, John W., Elizabeth Miller, Melegaro, Alessia, Yoon Hong Choi, E. Miller, Choi, Yoon Hong, Gay, Nigel J, Edmunds, W John, Nigel J Gay, R. George, W John Edmunds, Alessia Melegaro, N.J. Gay, W.J. Edmunds, Gay, Nigel J.   +18 more
core   +1 more source

Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence

Human Vaccines & Immunotherapeutics, 2021
Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV ...
Taeyong Lee, Jiyeon Suh, Jae-Ki Choi, Jeehyun Lee, Sun Hee Park   +4 more
doaj   +1 more source

Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan

Human Vaccines & Immunotherapeutics, 2021
A national immunization program using two doses of live attenuated varicella vaccine was introduced for children aged one to two years in Japan in October 2014.
Yosuke Yasui, Toshikatsu Mitsui, Fujiyo Arima, Keiko Uchida, Mikako Inokuchi, Mitsuaki Tokumura, Tetsuo Nakayama   +6 more
doaj   +1 more source

Varicella vaccines and measles, mumps, rubella, and varicella vaccine

Jornal de Pediatria, 2006
To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella.Bibliographic review of the MEDLINE and LILACS databases covering the period 1999 to 2006.The varicella vaccine protects 70 to 90% of ...
Lucia Ferro, Bricks, Helena Keico, Sato, Gabriel Wolf, Oselka   +2 more
openaire   +2 more sources

Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.

PLoS ONE, 2022
BackgroundVaricella is a contagious disease caused by varicella-zoster virus and varicella vaccine (VarV) is the most effective way to prevent and control varicella.
Jing Wang, Zhenhui Xu, Qiang Gao
doaj   +1 more source

Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.

PLoS ONE, 2021
IntroductionIn 2015, varicella vaccine was introduced to the National Immunization Programme in a one-dose regimen for infants aged 15 months. The aim of this study was to describe and compare the epidemiologic characteristics, management strategies and ...
Angela Gentile, Norberto Giglio, Maria Florencia Lucion, Ana Clara Martínez, Natalia Pejito, Maria Del Valle Juarez   +5 more
doaj   +1 more source

Correlation of protection against varicella in a randomized phase III varicella-containing vaccine efficacy trial in healthy infants / [PDF]

, 2021
Background: Varicella vaccination confers high and long-lasting protection against chickenpox and induces robust immune responses, but an absolute correlate of protection (CoP) against varicella has not been established.
Usonis, Vytautas,, Esposito, Susanna,, Wysocki, Jacek,, Povey, Michael,, Henry, Ouzama,, Prymula, Roman,, Ravault, Stéphanie,, Gillard, Paul,, Carryn, Stephane,, Habib, Md Ahsan,   +9 more
core   +2 more sources

Varicella vaccine

Vaccine, 1995
The varicella vaccine developed by Takahashi and cols. in 1974, in Japan, shows outstanding features. Its development, site and route of administration and final results are reviewed in this article.The varicella vaccine is highly effective in normal children (with almost 100% seroconversion rate), and with good protective responses in ...
openaire   +4 more sources

Impact of subsidies and socioeconomic status on varicella vaccination in Greater Tokyo, Japan

Frontiers in Pediatrics, 2016
Background: Although the control of varicella outbreaks is an important health issue, cost could present a major barrier for vaccination The aim of this study is to investigate the association of vaccine subsidies and caregivers’ socioeconomic status ...
Kei eNagaoka, Takeo eFujiwara
doaj   +1 more source